Coordinating and delivering research in the pandemic: The UK approachThe acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical Share XCoordinating and delivering research in the pandemic: The UK approachhttps://pharmaphorum.com/webinars/uk-covid-coroavirus-research-nihr/
Increasing patient engagement with UK clinical trialsPharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/
Introducing the new NIHR National Patient Recruitment CentresThe five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical Share XIntroducing the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/
Clinical decision-making insights for haem/oncsDespite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several Share XClinical decision-making insights for haem/oncshttps://pharmaphorum.com/oncology/clinical-decision-making-insights-haem-oncs/
COVID-19 May Briefing: The UK&I Healthcare Ecosystem FightbackThe third webinar* in the COVID-19 monthly briefing series was designed to provide insight from life sciences thought-leaders Share XCOVID-19 May Briefing: The UK&I Healthcare Ecosystem Fightbackhttps://pharmaphorum.com/r-d/covid-19-may-briefing-the-uki-healthcare-ecosystem-fightback/
The new global digital health paradigm in life sciencesDigital transformation has long been a priority for all life science companies and it has been made even Share XThe new global digital health paradigm in life scienceshttps://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/
COVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechOverview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications Share XCOVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechhttps://pharmaphorum.com/r-d/iqvia-covid-19-april-briefing-impact-for-pharma-and-biotech/
How ‘thinking modular’ might ease digital content overload in pharmaOverview In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based Share XHow ‘thinking modular’ might ease digital content overload in pharmahttps://pharmaphorum.com/sales-marketing/how-thinking-modular-might-ease-digital-content-overload-in-pharma/
Applying behavioural interventions in chronic diseasesOverview Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on Share XApplying behavioural interventions in chronic diseaseshttps://pharmaphorum.com/sales-marketing/applying-behavioural-interventions-in-chronic-diseases/
